Shares of ReShape Lifesciences (NASDAQ:RSLS) will reverse on Monday, September 23

Shares of ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report ) are set to reverse before the market opens on Monday, September 23rd. The 1-58 reverse split was announced on Thursday, September 19th. The number of shares held by shareholders will be adjusted after the closing bell on Friday, September 20th.

ReShape Lifesciences Price Performance

RSLS traded down $0.03 during trading hours on Thursday, reaching $0.12. 3,117,092 shares of the company’s stock were exchanged, compared to its average volume of 2,681,684. ReShape Lifesciences has a 12-month low of $0.12 and a 12-month high of $0.68. The firm has a 50-day moving average of $0.18 and a 200-day moving average of $0.18.

ReShape Lifesciences (NASDAQ:RSLS – Get Free Report ) last posted its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.06) EPS for the quarter. ReShape Lifesciences had a negative return on equity of 208.37% and a negative net margin of 112.11%. The business had revenue of $1.97 million during the quarter.

Changes in Analyst Ratings

Separately, Maxim Group reaffirmed a “hold” rating on shares of ReShape Lifesciences in a research report on Wednesday, July 17th.

Get the latest stock report on ReShape Lifesciences

About ReShape Lifesciences

(Get a free report)

ReShape Lifesciences Inc provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe and internationally. The company’s product portfolio includes the Lap-Band System, a long-term minimally invasive treatment of severe obesity and more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy; Lap-Band 2.0 system, adjustable postoperatively to increase or decrease pressure on the band to optimize comfort and effectiveness of individual therapy; and ReShape calibration tubes, which conform to the lesser curvature of the stomach to reach the pylorus.

Further reading

Get news and reviews for ReShape Lifesciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReShape Lifesciences and related companies with MarketBeat.com ‘s FREE daily email newsletter.